Key transcripts, such as MPO, FCGR1A, DEFA4, and CD177, have been highlighted as potential biomarkers of colorectal cancer, underscoring the role of immune dysregulation in tumor development and progression [18,19]. The gene discussed is DEFA4; the disease is neoplasm.